Form EFFECT Ovid Therapeutics Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 24, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Business of Medicine: Michael J. Napoli, Jr. Launches New Firm to Help Healthcare Professionals Navigate the Legal Side of Modern Medicine
- NutriRise Announces Saffron 120 Caps as the #1 Saffron Choice Among Healthcare Professionals
- Bitcoin Price Prediction: BTC Risks a $50K Flush While AlphaPepe Builds the x100 Presale Gap Trade
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share